Company / CapEx per Share
CRESCENT BIOPHARMA, INC. CapEx per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.90
FY2025
5-year range
$0.00 / $0.90
FY2021-FY2025
Trend
+7709.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share changed +7710% YoY in FY2025, a notable deviation from the 4-year average annual change of +1943%.
Based on SEC 10-K filings.
0.90 in FY2025 with a 10-year CAGR of +70.5%.
Improved from $0.01 to $0.90 over the past 9 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +70.5%
Key checks
Key Insights
- CRESCENT BIOPHARMA, INC.'s capex per share has grown for 3 consecutive years.
- In FY2025, capex per share increased 7709.8% year-over-year.
- Lowest capex per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.90 | +7709.8% |
| FY2017 | $0.01 | +3.5% |
| FY2016 | $0.01 | +157.5% |
| FY2015 | $0.00 | -98.0% |
| FY2014 | $0.22 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026